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Background: Cichorium glandulosum Boiss. et Huet is used for treatment of liver disorders, and its effects are
attributed to sesquiterpenes. This study aims to investigate the hepatoprotective effects of a sesquiterpene-rich
fraction (SRF) from the aerial part of C. glandulosum on carbon tetrachloride (CCl4)-induced acute hepatotoxicity in
mice, and on priming with Bacillus Calmette–Guerin (BCG) followed by lipopolysaccharide (LPS)-induced
immunological liver injury in mice.
Methods: SRF was suspended in water and administered to mice at 0.05, 0.10 and 0.20 g/kg body weight for
7 consecutive days. An active control drug (bifendate pills) was suspended in distilled water and administered to
mice at 0.40 g/kg body weight for 7 consecutive days. Hepatotoxicity was induced by intraperitoneal injection of
0.1% CCl4 (0.2 mL/mouse) at 13 h before the last drug administration, or by tail intravenous injection of BCG
(0.2 mL/mouse) before the first drug administration and LPS (0.2 mL/mouse; 8 μg) at 15 h before the last drug
administration. Blood samples and the livers were collected for evaluation of the biochemical parameters of
aspartate aminotransferase (AST), alanine aminotransferase (ALT) and total bilirubin (TBIL).
Results: SRF significantly reduced the impact of CCl4 toxicity. The highest dose of SRF (0.20 g/kg) was the most
effective, reflected by significant reductions in the levels of AST (P = 0.001), ALT (P = 0.000) and TBIL (P = 0.009).
The serum enzymatic levels induced by BCG and subsequent LPS injection were significantly and dose-dependently
restored by SRF, reflected by significant reductions in the levels of AST (P = 0.003), ALT (P = 0.003) and TBIL
(P = 0.007) for the highest dose of SRF (0.20 g/kg).
Conclusion: SRF is hepatoprotective in animal models of chemical and immunological acute liver injury.Background
The liver is a vital organ that is vulnerable to many dis-
eases, such as hepatitis A, B, C and E, alcohol damage,
fatty liver, cirrhosis, cancer and drug damage [1,2]. Free
radicals are the main causes of liver diseases, and liver
ailments remain a serious health problem [3]. Carbon
tetrachloride (CCl4) is frequently used as a chemical in-
ducer of experimental tissue damage [4-6], owing to its
production of a free radical, trichloromethyl radical
(CCl3). Bacillus Calmette–Guerin (BCG) and subsequent* Correspondence: haji@ms.xjb.ac.cn
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reproduction in any medium, provided the orlipopolysaccharide (LPS) injection provokes hepatic in-
jury in mice [7], and is considered to be a useful experi-
mental model for immunological liver injury [8].
Despite studies for a decade as well as advancement of
our understanding of the molecular pathogenesis of liver
diseases, the effective therapeutic interventions for liver
diseases are still limited [5]. Antioxidant therapy inhibits
deleterious oxidative changes, and has always been con-
sidered to be an important tool for liver disease treat-
ments. Medicinal plants, especially those with traditional
use, are considered to be a rich source of new effective
drugs.
Cichorium glandulosum Boiss. et Huet was reported
effective as a cholagogic and diuretic agent to improve
the appetite, to increase digestion, and to cure variousl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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roots, seeds, and aerial part of C. glandulosum have
been well documented during long-term clinical prac-
tice [10]. The pharmacologically active constituents of
C. glandulosum include a number of sesquiterpenoids
and flavonoids, such as lactucin, lactucopicrin, 11β,13-
dihydrolactucin and esculetin from the roots of C.
glandulosum [11,12], and cichoriin quercetin-3-O-β-D-
glucuronide and kaempferol-3-O-β-D-glucuronide from
the aerial part of C. glandulosum [13]. These compounds
demonstrate significant anticancer [14,15], antimalarial
[16], analgesic and sedative [17] and anti-inflammatory
[18] activities.
This study aims to investigate the in vivo activity of
SRF against experimental liver injury caused by adminis-
tration of CCl4 and BCG + LPS, respectively.
Methods
Chemicals and reagents
CCl4 was purchased from Tianjin No. 3 Chemical Re-
agent Factory (China) (batch no. 20110925). Ybarra
extra virgin olive oil was produced by Aceites Ybarra S.
A. (Spain) (batch no. 20101026). BCG vaccine for intra-
dermal injection was produced by Shanghai Institute of
Biological Products Co. Ltd. (China) (batch no.
201011054–1). Sterilized water for injection was pro-
duced by Jiangsu Tianhe Disainuo Pharmaceutical Co.
Ltd. (China) (batch no. 20110523.2). LPS was purchased
from Sigma Corporation (USA) (batch no. L-2880). So-
dium chloride (0.9%) injection was produced by Sino-
pharm Group Xinjiang Pharmaceutical Co. Ltd. (China)
(batch no. 20120210). Assay kits for serum aspartate
aminotransferase (AST), alanine aminotransferase (ALT)
and total bilirubin (TBIL) were purchased from Biosino
Bio-Technology & Science Inc. (China) (batch no. 110861,
111761 and 110721 respectively). All other chemicals were
of analytical grade.
Plant materials
C. glandulosum Boiss. et Huet was collected in Hutan
County, China, in November 2007. The plant was identi-
fied by Dr. LY Zhang (Xinjiang Institute of Ecology and
Geography, Chinese Academy of Sciences, Urumqi,
China), where voucher specimens (no. 051054 and
051055) have been deposited.
Preparation of SRF
The air-dried aerial part of C. glandulosum (125 kg) was
extracted twice with ethanol (40%) at 60°C for 3 h with
refluxing in a water bath at a raw material/extractant
ratio of 1:15. The ethanol was vacuum-distilled from the
combined extract using a rotary vacuum evaporator
(Rotavapor R-220; Buchi, Switzerland) at 60°C until a
relative density of 1.01–1.05 (60°C) was achieved withthe density bottle method [19]. The aqueous residue was
then added (1150 mL/min) to a column packed with
HPD-100 macroporous adsorption resin (Cangzhou
Bonchem Co., Ltd., China) at an aqueous residue/resin
ratio of 6:1 (v/v) and incubated for 6 h to allow absorp-
tion. Subsequently, the resin was washed with water at
4× the resin volume (1960 mL/min), and the eluent was
discarded. The resin was then washed with ethanol
(60%) at 6× the resin volume (1150 mL/min). The eluent
was concentrated using the rotary vacuum evaporator
and vacuum-dried to obtain SRF (950 g).
Animals
Kunming mice (18–22 g) of either sex were purchased
from the Experimental Animal Center of the Center for
Disease Control of Xinjiang (China). The mice were
kept in a specific room at a temperature at 21–23°C on
a 12-h/12-h light/dark cycle (lights on from 08:00 h to
20:00 h), and provided with rodent chow and water ad
libitum. The investigation conformed to the Guide for
the Care and Use of Laboratory Animals (NRC), 2010.
CCl4-induced hepatotoxicity
The protective effect of SRF treatment against CCl4-
induced hepatotoxicity in mice was evaluated in a 7-day
study. The animals were arbitrarily divided into six ex-
perimental groups with 10 mice/group. Group I served
as a control and received distilled water only (0.2 mL/10
g body weight) during the experiment. Group II was
given distilled water (0.2 mL/10 g body weight) for 7
days before CCl4 intoxication and served as a hepatotox-
icity control group. Group III was given bifendate (0.40
g/kg body weight) for 7 days before CCl4 intoxication
and served as a positive control group. Groups IV, V and
VI were prophylactically treated perorally for 7 days with
three different doses of SRF suspension (0.05, 0.10 and
0.20 g/kg/day, respectively). The mice in groups II–VI
received an intraperitoneal injection of CCl4 (0.2 mL/
mouse of 0.1% CCl4 solution in olive oil) 13 h before the
final administration. The control group was intraperito-
neally treated with an equal amount of olive oil. The ani-
mals were euthanized at 1 h after the CCl4 intoxication
and olive oil treatment. Blood samples were collected for
evaluation of the biochemical parameters.
BCG + LPS-induced hepatotoxicity
To examine the effect of SRF on BCG + LPS-induced
liver injury, mice were arbitrarily divided into six experi-
mental groups with 10 mice/group. Group I was a con-
trol group, group II was a hepatotoxicity control group,
group III was a positive control group and groups IV, V
and VI were SRF pretreatment groups. Each group was
given a tail intravenous injection of BCG (0.2 mL/
mouse) before the first drug administration. Groups IV–
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0.10 and 0.20 g/kg body weight, respectively) once a day
for 7 days. Group I was given distilled water only (0.2
mL/10 g body weight) and group III was orally adminis-
tered bifendate (0.40 g/kg body weight). On day 7, at 15
h before the last administration, groups II–VI were given
a tail intravenous injection of LPS in normal saline (0.2
mL/mouse; 8 μg) and group I was given a tail intraven-
ous injection of an equal amount of saline solution.
Blood samples for the biochemical analyses were taken
at 1 h after the last administration.
Determination of biochemical markers of hepatic injury
The collected blood samples were centrifuged (877 × g,
10 min, 4°C) and the serum samples were separated and
stored at −20°C until analysis. The activities of AST,
ALT and TBIL were determined using Aspartate Amino-
transferase Kit, Alanine Aminotransferase Kit and Total
Bilirubin Kit.(Bilsino Biotechnology Company Ltd.,
China). Enzyme activities were expressed as inter-
national units (U/l or μmol/L).
Histological examination
Mice were euthanized under light ether anaesthesia at 1
h after the last dosage and the livers were removed and
washed with normal saline. The liver tissues were fixed
in 10% formalin, dehydrated in a series of ethanol solu-
tions and embedded in paraffin. The paraffin-embedded
tissues were cut into 5–6-μm sections,and stained with
haematoxylin and eosin (HE). The histopathological
characteristics were observed and recorded with an
HPLAS-1000 Colorized Pathology Image Analyzer
(Tongji Medical University Qian-ping Image Engineer-
ing Company, China).
Statistical analysis
Results were expressed as the mean ± standard deviation
(SD). Statistical analyses of data were performed with
the SPSS 16.0 statistical package (IBM, USA). All statis-
tical comparisons were performed by one-way ANOVA
followed by Tukey’s test. P values of less than 0.05 wereTable 1 Protective effects of SRF on CCl4-induced increases in
Groups Pretreatment (g/kg) AST (U/l)
Group I Vehicle 213.76 ± 33
Group II Vehicle 968.58 ± 43
Group III 0.40 426.11 ± 14
Group IV 0.05 779.79 ± 40
Group V 0.10 676.55 ± 38
Group VI 0.20 380.09 ± 17
Values are expressed as the mean ± SD of 10 mice/group.
**P < 0.01, significant difference vs. the group I.
#P < 0.05, significant difference vs. the group II.
##P < 0.01, significant difference vs. the group II.considered statistically significant and P values of less
than 0.01 were considered highly significant. The dose-
dependent relationships were visually determined.
Results
Effects of SRF on CCl4-induced liver injury
The effects of SRF on the biochemical markers in mice
with CCl4-induced liver injury are shown in Table 1.
After a single injection of CCl4, the activities of AST
(P = 0.000) and ALT (P = 0.000) in group II were signifi-
cantly increased to 968.58 ± 439.52 and 984.98 ± 381.14
U/l, respectively, and TBIL was elevated to 10.09 ± 2.37
μmol/L, compared with group I (213.76 ± 33.81 U/l,
62.87 ± 10.84 U/l and 9.49 ± 2.21 μmol/L, respectively).
The activities of AST (P = 0.000), ALT (P = 0.004) and
TBIL (P = 0.010) were significantly reduced in group III
administered bifendate -(0.40 g/kg body weight). Pre-
treatment with different doses of SRF in groups IV, V
and VI (0.05, 0.10 and 0.20 g/kg body weight, respect-
ively) for 7 days reduced the activities of AST, ALT and
TBIL compared with the group II- Of these, the highest
dose of SRF (0.20 g/kg body weight) was the most effect-
ive, reflected by significant reductions in the levels of
AST (P = 0.001), ALT (P = 0.000) and TBIL (P = 0.009).
The effects were dose-dependent, but the large SDs in
all three SRF-pretreated groups indicated persistence of
inter-individual variability in drug responses between the
mice-, taking into account the large number of animals
in each group (Table 1).
The histological observations supported the results of
the serum enzyme assays. The liver sections in group I
showed the normal lobular architecture and normal
hepatic cells with a well-preserved cytoplasm and well-
defined nucleus and nucleoli (Figure 1). Histopatho-
logical examination of the liver sections in group II
showed centrilobular necrosis, ballooning degeneration,
inflammatory infiltration and fatty changes. The liver
sections in groups IV, V and VI revealed that SRF was
able to prevent the development of histopathological
changes in a dose-dependent manner. The liver sections
of mice pretreated with the highest dose (0.2 g/kg bodyAST, ALT and TBIL
ALT (U/l) TBIL (μmol/L)
.81 62.87 ± 10.84 9.49 ± 2.21
9.52** 984.98 ± 381.14** 10.09 ± 2.37
5.43## 133.47 ± 71.92## 7.13 ± 2.24##
1.47# 714.15 ± 317.77# 7.90 ± 3.04
2.08# 681.09 ± 261.49# 7.69 ± 1.14#
9.40## 279.35 ± 164.26## 7.44 ± 0.95#
Figure 1 Histopathologic sections of the liver in the CCl4-induced model. (Group I) Liver sections of normal healthy mice show normal
arrangements of cells in the liver lobules. (Group II) Hepatocyte necrosis and evident vacuolation of hepatocytes are observed in liver sections of
CCl4-treated mice. (Group III and Group IV) Liver sections of mice pretreated with bifendate at 0.40 g/kg body weight (Group III) or SRF at 0.05
g/kg body weight (Group IV) show mild vacuolation of hepatocytes. (Group V) Mice pretreated with SRF (0.10 mg/kg body weight) show very
mild hepatocyte necrosis and mild vacuolation of hepatocytes. (Group VI) Liver sections of mice pretreated with SRF (0.20 mg/kg body weight)
show marked improvement in the histology compared with the CCl4-treated control group. HE staining; 100× magnification.
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Table 2).
Effects of SRF on BCG + LPS-induced liver injury
The effects of SRF on the biochemical markers in mice
with BCG + LPS-induced liver injury are shown inTable 2 Effects of SRF on histopathological findings in
mice with CCl4-induced liver damage
Groups AHN AHFC AII
+ ++ + ++ + ++
Group I 0 0 2 0 2 0
Group II 4 1 3 1 3 0
Group III 2 1 2 0 2 0
Group IV 2 2 3 0 3 0
Group V 1 1 4 0 2 0
Group VI 2 0 4 0 1 0
A total of 10 mice were examined per group.
AHN, animals with hepatocellular necrosis; AHFC, animals with hepatocellular
fatty change; AII, animals with inflammatory cell infiltration.Table 2. After a single injection of BCG + LPS, the activ-
ities of AST (P = 0.021) and ALT (P = 0.009) in group II
were significantly increased to 222.44 ± 25.93 and 60.17
± 7.43 U/l, respectively, and TBIL was elevated to 7.58 ±
1.41 μmol/L, compared with group I (197.02 ± 18.24 U/
l, 51.67 ± 5.64 U/l, and 7.34 ± 1.41 μmol/L, respectively).
The activity of ALT was significantly decreased (P =
0.000) with reductions in AST and TBIL in group III
administered bifendate -(0.40 g/kg body weight). Pre-
treatment with different doses of SRF in groups IV, V
and VI (0.05, 0.10 and 0.20 g/kg body weight, respect-
ively) for 7 days reduced the activities of serum AST,
ALT and TBIL compared with group II. The effects were
dose-dependent, but the large SDs in all three pretreat-
ment groups indicated the persistence of inter-individual
variability in the drug responses between the mice, tak-
ing into account the large number of animals in each
group (Table 3).
The histological observations supported the results of
the serum enzyme assays. The liver sections in group I
Table 3 Protective effects of SRF on BCG + LPS-induced increases in AST, ALT and TBIL
Groups Pretreatment (g/kg) AST (U/l) ALT (U/l) TBIL (μmol/L)
Group I Vehicle 197.02 ± 18.24 51.67 ± 5.64 7.34 ± 1.41
Group II Vehicle 222.44 ± 25.93* 60.17 ± 7.43** 7.58 ± 1.41
Group III 0.40 206.72 ± 31.70 37.04 ± 6.54## 7.42 ± 1.18
Group IV 0.05 220.04 ± 22.31 61.50 ± 7.94 6.80 ± 1.37
Group V 0.10 208.13 ± 16.99 56.37 ± 7.56 6.63 ± 0.77
Group VI 0.20 186.14 ± 20.44## 48.66 ± 7.27## 6.15 ± 0.46##
Values are expressed as the mean ± SD of 10 mice/group.
*P < 0.05, significant difference vs. the group I.
**P < 0.01, significant difference vs. the group I.
#P < 0.05, significant difference vs. the group II.
##P < 0.01, significant difference vs. the group II.
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hepatic cells with a well-preserved cytoplasm and
well-defined nucleus and nucleoli. Histopathological
examination of the liver sections in group II showed
centrilobular necrosis, ballooning degeneration, inflam-
matory infiltration and fatty changes. The liverFigure 2 Histopathologic sections of the liver in the BCG + LPS-induc
normal arrangements of cells in the liver lobules. (Group II) Hepatocyte ne
sections of BCG + LPS-treated mice. (Group III and Group IV) Liver section
III) or SRF at 0.05 g/kg body weight (Group IV) show mild vacuolation of h
mg/kg body weight (Group V) or 0.20 mg/kg body weight (Group VI) sho
treated control group. HE staining; 100× magnification.sections in groups IV, V and VI revealed that SRF
was able to prevent the development of histopatho-
logical changes in a dose-dependent manner. The liver
sections of mice pretreated with the highest dose (0.2
g/kg body weight) showed a well-preserved architec-
ture (Figure 2, Table 4).ed model. (Group I) Liver sections of normal healthy mice show
crosis and evident vacuolation of hepatocytes are observed in liver
s of mice pretreated with bifendate at 0.40 g/kg body weight (Group
epatocytes. (Group V and Group VI) Mice pretreated with SRF at 0.10
w marked improvement in the histology compared with the CCl4-
Table 4 Effects of SRF on histopathological findings in
mice with BCG + LPS-induced liver damage
Groups AHN AHFC AII
+ ++ + ++ + ++
Group I 0 0 2 0 0 0
Group II 5 1 7 0 5 1
Group III 3 1 7 0 3 1
Group IV 2 0 6 0 2 0
Group V 1 0 7 0 1 0
Group VI 1 0 5 0 1 0
A total of 10 mice were examined per group.
AHN animals with hepatocellular necrosis; AHFC, animals with hepatocellular
fatty change; AII, animals with inflammatory cell infiltration.
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In this study, we confirmed the efficacy of SRF from
the aerial part of C. glandulosum and examined its
hepatoprotective effects using two animal models of
hepatotoxicity.
CCl4 is a potent chemical hepatotoxin [20] that caused
hepatocellular damage, as clearly indicated by the mark-
edly elevated activities of serum enzymes (AST, ALT and
TBIL) compared with non-treated control mice. Regard-
ing the potential of SRF to prevent chemically-induced
hepatotoxicity, the highest tested dose (0.20 g/kg body
weight) was the most effective in this study. Although
the ALT and AST activities were still higher with the
highest dose of SRF than in the normal control animals,
our histopathologic analyses revealed normal liver hist-
ology in group VI, and evidence of hepatotoxicity, such
as hepatocellular necrosis, fatty changes, ballooning de-
generation and infiltration of lymphocytes, was not
detected.
Immune factors, such as autoimmune stimuli, virus in-
fection or parasite infection, are the predominant causes
of hepatic damage, especially under hepatitis [8]. The
commonly used models of liver injury, which are often
induced by chemicals, may not accurately reflect the
clinical situation [21]. In this study, a BCG/LPS-induced
liver injury model was used to investigate the hepatopro-
tective effects of SRF in mice. The elevated levels of ALT
and AST were reduced after treatment with SRF, with
the levels in group VI (0.20 g/kg body weight) reduced
to the levels in the normal control group. Taken to-
gether, these findings suggest that the hepatoprotective
effects of SRF may involve the ability for biomembrane
protection against free radicals.
The induced liver damage was assessed by the TBIL
activity in both models. Toxicity begins with changes
to the endoplasmic reticulum, which result in the loss
of metabolic enzymes located in the intracellular struc-
tures. SRF reduced the elevated TBIL levels, suggesting
that SRF has the ability to stabilize biliary dysfunctionin the mice liver during hepatic injury with CCl4 and
BCG + LPS.
Conclusion
SRF was hepatoprotective in animal models of chemical
and immunological acute liver injury.
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